
About
Ms. Faig has been a director of Henry Schein, Inc. since December 2023. Ms. Faig is a seasoned executive with extensive experience in healthcare and public accounting. After a distinguished 38-year career at Ernst & Young LLP (now known as EY LLP), she retired in July 2021. Throughout her time at EY, Ms. Faig held leadership roles in both national and regional capacities. As U.S. Health Sector Leader from 2017 to 2020, she spearheaded strategic expansion, driving significant revenue growth and market recognition for EY’s healthcare offerings. Concurrently, she led the West Region’s Health and Life Sciences market segment from 2019 to 2021, optimizing client services and overseeing revenue, operations, and personnel. From 1996 to 2018, she served as an audit partner, advising clients across the healthcare spectrum, from startups to large public companies. This experience provides her with a deep understanding of the industry’s complexities and challenges. Ms. Faig currently serves as the Audit Committee Chair on the boards of three companies – Cue Health, a Nasdaq-listed company, and Affinia Therapeutics and QuVa Pharma, private equity–backed private businesses. Throughout her professional career, Ms. Faig has been recognized for her leadership on matters related to diversity and inclusion. She served on EY’s Gender Equity Task Force and was awarded EY’s Chairman’s Value Award and Americas Assurance Inclusive Leadership Award in recognition of her commitment to building an inclusive workplace. Ms. Faig holds a Bachelor of Business Administration in accounting from Sam Houston State University and is a certified public accountant.
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
| Company | Committee | Position | Date Appointed |
|---|---|---|---|
![]() | Audit | Chairperson |
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| Henry Schein, INC. | Board | Member | 01/12/2023 | |
| Henry Schein, INC. | Audit | Member | 01/12/2023 | |
| Henry Schein, INC. | Other | Member | 01/12/2023 |
